Semaglutide for Weight Loss: The Complete Patient Guide

What Is Semaglutide?

Semaglutide is a GLP-1 receptor agonist — a medication that mimics GLP-1 (glucagon-like peptide-1), a natural gut hormone released after meals to signal fullness, slow digestion, and regulate insulin. Semaglutide mimics this hormone with far greater potency and duration, creating a sustained state of reduced appetite, slower gastric emptying, and improved blood sugar control. Originally developed for type 2 diabetes (Ozempic), it received FDA approval for weight management at a higher dose (Wegovy) and has become one of the most impactful medical interventions for obesity in history.

How Semaglutide Causes Weight Loss

The weight loss from semaglutide goes beyond simply eating less — it changes the hormonal signals that regulate hunger, reward, and satiety at a neurological level.

• ✓Reduces appetite: Acts on GLP-1 receptors in the hypothalamus to decrease hunger signals
• ✓Slows gastric emptying: Food stays in the stomach longer, increasing satiety after smaller meals
• ✓Reduces food noise: Many patients report a dramatic reduction in constant thoughts about food
• ✓Improves insulin sensitivity: Helps cells respond better to insulin, reducing metabolic dysfunction that drives fat storage
• ✓Reduces visceral fat preferentially: Clinical trials show greater reduction in liver fat and visceral adipose tissue than subcutaneous fat
• ✓Long-term metabolic reset: Sustained weight loss has been shown to reduce cardiovascular risk, improve sleep apnea, and reduce joint load

The Titration Schedule

Semaglutide must be started at a low dose and titrated slowly. The most common reason patients drop out is escalating too fast and experiencing severe GI side effects. Your body needs time to adapt.

• ✓Weeks 1-4: 0.25mg weekly — tolerance dose, not therapeutic
• ✓Weeks 5-8: 0.5mg weekly — first modest appetite suppression for most patients
• ✓Weeks 9-12: 1.0mg weekly — meaningful weight loss typically begins here
• ✓Weeks 13-16: 1.7mg weekly — if tolerated and more weight loss is needed
• ✓Week 17+: 2.4mg weekly (Wegovy maximum dose)
• ✓Stay at any dose an extra 4 weeks if GI side effects are significant — tolerability over speed

What to Expect Each Phase

Setting accurate expectations is one of the most important things a provider can do to prevent early dropout.

• ✓Month 1: Little to no weight loss (dose is sub-therapeutic). Some appetite reduction. GI side effects may be present.
• ✓Month 2: 3-5% weight loss typical. Appetite clearly reduced. Many patients stop finishing meals.
• ✓Month 3-4: 7-10% weight loss. Food noise reduction becomes very noticeable. Energy often improves.
• ✓Month 5-6: 10-15% weight loss. Body composition changes visible. Some patients reach their goal.
• ✓Month 6-12: Average 15% weight loss with full titration and adherence. Some achieve 20%+ with lifestyle optimization.

Managing Side Effects

GI side effects are the primary barrier to successful therapy. Most can be prevented or minimized with proactive management.

• ✓Nausea: Eat smaller meals, avoid greasy or spicy food, take your injection before bed. Ginger tea or supplements help. Ondansetron prescribed PRN for severe cases.
• ✓Constipation: The most underreported side effect. Increase fiber, stay hydrated, consider magnesium citrate or psyllium husk.
• ✓Diarrhea: Less common, usually early. Reduces dose temporarily if severe.
• ✓Reflux/heartburn: Common due to slower gastric emptying. Avoid lying down after eating.
• ✓Fatigue: Often transient in the first weeks, usually improves as the body adapts.

Nutrition Strategy on Semaglutide

Semaglutide dramatically reduces appetite — but eating less does not automatically mean eating well. Without intentional nutrition, patients lose muscle alongside fat, leading to worse body composition and a lower metabolism after stopping.

• ✓Protein is non-negotiable: Target 0.7-1g per pound of body weight daily. With reduced appetite, this requires deliberate effort.
• ✓Eat protein first at every meal: Fill up on protein before carbohydrates or fat.
• ✓Liquid calories still count: Semaglutide reduces solid food appetite more than liquid. Watch alcohol, juices, and caloric drinks.
• ✓Resistance training: Critical for preserving muscle during rapid weight loss. Even 2-3 sessions per week significantly improves outcomes.

Labs to Monitor

Responsible semaglutide therapy includes baseline and follow-up lab monitoring.

• ✓Baseline: HbA1c, fasting glucose, fasting insulin, lipid panel, liver enzymes, kidney function, TSH, calcitonin
• ✓Recheck at 3 months: HbA1c, glucose, lipids, liver enzymes
• ✓Ongoing: Every 6 months while on therapy
• ✓Body composition: DEXA scan or assessment at baseline and 6 months to confirm fat loss vs. muscle loss
• ✓Watch for: Pancreatitis symptoms (severe abdominal pain); gallbladder symptoms (rapid weight loss increases gallstone risk)

What Happens When You Stop?

Weight regain after stopping semaglutide is a known phenomenon — the STEP 4 trial showed patients who discontinued regained most weight within one year. This reflects that obesity is a chronic disease requiring ongoing management. Long-term options include continuing at a maintenance dose, transitioning to tirzepatide for greater effect, or combining with lifestyle interventions and peptides like CJC-1295/Ipamorelin that support body composition maintenance. Discuss a long-term management plan with your provider before you start — not after you stop.